Arize, by Similac, is the first and only hydrolysed rice protein iFSMP* available in the UK and contains synthesised 2’-fucosyllactose (2’-FL†) human milk oligosaccharide (HMO). Arize has been specially formulated for the dietary management of infants with cow’s milk protein allergy (CMPA) or other conditions where an extensively hydrolysed formula is clinically indicated.
Breast milk is the gold standard providing not only nutrition, but protection and support for the developing immune system.1-3 However, not every infant with allergies can be breastfed and a number of families depend on hypoallergenic formula.
Hydrolysed rice formulas (HRFs) are an established option for managing CMPA4-6 and have been recommended as a first line option by DRACMA and ESPGHAN guidelines for over 10 years.7,8
HRFs are shown to be nutritionally adequate and well tolerated in the dietary management of infants with CMPA:9,10
Arize is designed to work first-line, 100% of the time in mild-to-moderate CMPA:12-14
Arize contains 2'-FL and nucleotides, which supports the immune system,19,22-23 and is fortified with lysine, threonine and tryptophan, bringing its amino acid composition closer to that of human milk than other HRFs.5
Arize has a high acceptance rate from as early as the first feed.24
Arize is a HRF, designed specifically to meet the nutritional needs of infants while managing CMPA and other conditions where an extensively hydrolysed formula (eHF) is clinically indicated.
Learn more about the benefits of HRFs in the management of CMPA and make an informed prescription choice that meets the highest standards for your patients’ health, growth and development.
Suitable for
| Suitable for
| Suitable for
| Clinically
| Gluten free |
|---|---|---|---|---|
| à | à | à | æ | à |
¶ Maximum lactose content <68mg/L as fed, <10mg/100kcal
Arize is a Food for Special Medical Purposes for infants, for use under medical supervision.
Nutrition | Per 100 ml | Per 200 ml |
|---|---|---|
Energy | 287 kJ / 68 kcal | 631 kJ / 149 kcal |
Protein | 2.0 g | 4.4 g |
Similac® High Energy
Similac High Energy is a 1.0 kcal/ml, nutritionally complete, high energy, ready-to-use infant formula for special medical purposes for infants from birth to 8 kg with, or at risk of, faltering growth. It is particularly suitable for infants who may have increased energy requirements or are fluid restricted. Similac High Energy is available in 200 ml bottles, which attach directly to Abbott giving sets
PaediaSure®
PaediaSure provides 1.0 kcal/ml and is suitable for the dietary management of children weighing 8-30 kg or aged 1-10 years with, or at risk of developing, disease-related malnutrition.
PaediaSure® Compact
PaediaSure Compact is a 125 ml oral nutritional supplement suitable for the dietary management of children weighing 8 - 30 kg with, or at risk of developing, disease-related malnutrition. It has been specifically developed for children who may benefit from a smaller volume, as an alternative to ready-to-drink supplements which are 200 ml in volume. Each bottle provides 301 kcal (2.4 kcal/ml) and 8.4 g of protein. The milkshake style oral nutritional supplement is ready-to-drink and available in three delicious flavours: banana, strawberry and vanilla.
Pedi R‐MAPP a nutritional awareness tool, support consultation with children
Support upskilling of dietitians to complete TECs assessments, BDA Paediatric Specialist Group developed guidance on how to complete remote dietetic consultations for HCPs working in paediatric primary healthcare
Parents of Babies with Cow’s Milk Allergy Face Long and Emotional Journey
Cow’s milk allergy (CMA) usually develops in the first year of life and is one of the most common food allergies among children. MomenTums.co.uk, powered by Abbott, is a comprehensive resource for parents of children with special nutritional needs, including CMA. A series of practical guides for parents are also available to download from the site. These include: Allergy Versus Intolerance infographic; Preparing to Visit Your Child’s Healthcare Professional; Practical Strategies for Parents; Cookbook of Cow’s Milk Free Recipes for Children.
New Guidelines & Position Papers in Paediatric Nutrition: a 2015-2020 Overview
The aim of this overview is to provide the latest information from the past five years, concerning major nutritional recommendations and systematic reviews in children in general and in specific diseases and to discuss progression in the field of paediatric evidence-based nutrition practice. Key tables summarise the most reported nutrition topics in specific diseases and the recommendations for the use of micronutrients, and some remarkable issues that were noticed are discussed.
Footnotes:
DRACMA - Diagnosis and Rationale for Action against Cow's Milk Allergy
ESPGHAN - European Society for Paediatric Gastroenterology, Hepatology and Nutrition
*iFSMP - Food for special medical purposes for infants
†2’-FL - 2’-fucosyllactose. Structurally identical to that found in breast milk (not sourced from human milk).
‡Made from Extensively Hydrolysed Rice Protein.
§Resulted in zero reactions in two hypoallergenicity studies conducted in Risolac® now called Arize. Rice hydrolysate identical in both formulations.
References:
1. Kainonen E, et al. Immunological programming by breast milk creates an anti-inflammatory cytokine milieu in breast-fed infants compared to formula-fed infants. Brit J Nutrition 2013;109(11):1962–1970.
2. Walker A. Breast milk as the gold standard for protective nutrients. J Pediatr 2010;156(Suppl 2):S3–S7.
3. Lessen R, Kavanagh K. Position of the academy of nutrition and dietetics: promoting and supporting breastfeeding. J Acad Nutr Diet 2015;115(3):444–449.
4. Bocquet A, et al. Arch Pediatr. 2019;26(4):238–246.
5. Dupont C, et al. Nutrients. 2020;12(9):E2654.
6. Helm RM, Burks AW. Cereal Foods World. 1996;41(11):839-843
7. Fiocchi A, et al. World Allergy Organ J. 2010;3(4):57-161
8. Koletzko S, et al. J Pediatr Gastroenterol Nutr. 2012;55(2):221–229
9. Fiocchi A, et al. World Allergy Organ J. 2022;15(12):100717.
10. Bejarano R, et al. JSM Nutr Disord. 2022;4(1):1011.
11. Anania C, et al. J Clin Med. 2022;11(16):4823.
12. Fiocchi A, et al. Clin Exp Allergy. 2003;33(11):1576–1580.
13. Fiocchi, A et al. Clin Exp Allergy. 2006;36(3):311–316.
14. Fiocchi A, et al. World Allergy Organ J. 2016;9(1):35.
15. Agostoni C, et al. Pediatr Allergy Immunol. 2007;18(7):599–606.
16. Reche M, et al. Pediatr Allergy Immunol. 2010;21(4 Pt 1):577–585.
17. Vandenplas Y, et al. Eur J Pediatr. 2014;173(9):1209–1216.
18. D’Auria E, et al. J Int Med Res. 2003;31(3):215–222.
19. Reverri EJ, et al. Nutrients. 2018;10(10):1346.
20. Merolla R, Sperimentatori GP. Minerva Pediatr. 2000;52(12):699–711.
21. Gutiérrez-Castrellón P, et al. Br J Nutr. 2007;98(Suppl 1):S64–S67.
22. Marriage BJ, et al. J Pediatr Gastroenterol Nutr. 2015;61(6):649–658.
23. Goehring KC, et al. J Nutr. 2016;146(12):2559–2566
24. Abbott. Data on File. Similac Arize. 2021.
SESSION TIMEOUT
You have now gained access to ProConnect for a limited time. We will now verify your details before your account becomes fully active.
You are now able to freely access all resources and education during this visit to the ProConnect website. An email will be sent to you within 2 working days to activate your account which will complete your registration process.
Added to Bag
ENSURE PLUS
1 x 220 ml
Flavor: Apple
1,5 kcal / ml
Nutrition Information
| Unit | Per {ml-col-1} ml | Per {ml-col-2} ml |
| Unit | Per {ml-col-1} ml | Per {ml-col-2} ml |
| Unit | Per {ml-col-1} ml | Per {ml-col-2} ml |
footnotes
Product details not available.
You are about to exit for another Abbott country or region specific website.
Please be aware that the website you have requested is intended for the residents of a particular country or region, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions.
The website you have requested also may not be optimised for your specific screen size.
Do you wish to continue and exit this website?
UK-N/A-2200465 | July 2022
This website is for UK HCPs and UK Patients only. If you are outside of the UK please visit our global website Abbott.com
If you choose "I am a patient/carer”, you will be entering a website intended for patients and carers which has information on Abbott products. Products on this website are to be used under medical supervision. If you have questions about the product information discussed on this website, you should consult with your healthcare professional.
Stay Connected